Kasandra A. Aneses, PA-C

Kasandra Aneses practices at Strong Memorial Hospital in Rochester, New York, part of University of Rochester Medical Center.

Kasandra Aneses' NPI, 1699804831, was assigned on March 5, 2007. Kasandra Aneses holds New York license 017520.

Kasandra Aneses' primary practice is Strong Memorial Hospital, at 601 Elmwood Ave, Rochester, NY 14642 in Monroe County. The practice phone is (585) 275-2121.

Kasandra Aneses' primary practice is Strong Memorial Hospital in Rochester, New York, part of University of Rochester Medical Center. Kasandra Aneses is also affiliated with Highland Hospital. The medical group on file is URMC Cardiology.

Dmand AI tracks the electronic health record (EHR) system at each site where Kasandra Aneses practices, 2 sites in all. Vendor and product names are available with a free account.

Medical is Kasandra Aneses' primary specialty in the NPI Registry, under taxonomy code 363AM0700X. Kasandra Aneses is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Dmand AI has Kasandra Aneses' licenses on file in 2 states: New York and Florida.

Dmand AI lists sleep apnea among the conditions Kasandra Aneses treats.

CMS data shows 179 Medicare services from Kasandra Aneses across 3 procedure codes in 2024, for 112 Medicare patients. Medicare paid $7,071 for them. Every service was in an office.

CMS counts 112 Medicare patients who saw Kasandra Aneses in 2024. The largest group is 65 to 74, with 40 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 29% are also on Medicaid. Their average risk score is 1.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Kasandra Aneses' median patient age at 72, with 54% women.

In 2024, Kasandra Aneses wrote 2,842 Medicare Part D claims for 998 patients. 80% of them were for generic drugs. CMS names the drug for 2,588 of them, across 34 drugs with 11 or more claims each, at $629,876 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Kasandra Aneses for performance year 2024, reported as part of a group. Kasandra Aneses accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Kasandra Aneses as offering telehealth.

CMS Open Payments shows 1 general payment to Kasandra Aneses from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Boston Scientific Corporation paid the most, $20.